Our observations suggest that LPP3 serves as an intrinsic negative regulator of SMC phenotypic modulation and inflammation after vascular injury, in part, by regulating lysophospholipid signaling. These findings may provide a mechanistic link to explain the association between a PPAP2B polymorphism and coronary artery disease risk.
No takes yet. Share an insight, caveat, or question.
Panchatcharam et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: